The SPEEDCELL project is a four-year EU-funded initiative led by HIPRA
To accelerate the development and production of biologics, enabling a swift response to health emergencies, aligned with the EU’s “100 Days Mission”.
Year project
0
EUR Funding
0M
Time reduction goal in production
%
Days goal
0
Accelerate the development and production of biologics
The project aligns with European strategies to strengthen health security and address systemic medicine shortages, particularly in the context of health crises and pandemics.
CHALLENGES
Reducing the time-to-market
For new vaccines and therapeutic biologics in response to emerging health threats.
Manufacturing infrastructure
Building a flexible, multi-technology manufacturing infrastructure capable of rapidly pivoting to new targets.
Production scalability
Improving production scalability while maintaining product safety, efficacy, and quality.
Europe’s strategic autonomy
Contributing to Europe’s strategic autonomy in the field of pandemic preparedness and biopharmaceutical production.
MISSION
SPEEDCELL’s mission is to boost Europe’s ability to respond to health emergencies by streamlining cell line development and manufacturing.